PLUR · XBRL financial data

Pluri financial statements, every quarter

The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal quarters (PLUR's year ends in late June)

In thousands of dollars	Q1 FY24Sep 30, 2023	Q2 FY24Dec 31, 2023	Q3 FY24Mar 31, 2024	Q4 FY24Jun 30, 2024	Q1 FY25Sep 30, 2024	Q2 FY25Dec 31, 2024	Q3 FY25Mar 31, 2025	Q4 FY25Jun 30, 2025	Q1 FY26Sep 30, 2025	Q2 FY26Dec 31, 2025	Q3 FY26Mar 31, 2026	Q4 FY26Jun 30, 2026
Revenue	54	105	71	96*	326	185	427	398*	316	198	167	335*
Cost of revenue	—	—	—	year only	126	74	291	191*	201	112	111	139*
Gross profit	54	105	71	—	200	111	136	207*	115	86	56	196*
Research and development	3,366	2,964	3,094	3,395*	2,889	2,925	3,043	3,994*	3,931	3,826	3,962	3,373*
General and administrative	2,438	2,354	2,511	2,731*	2,509	2,143	2,493	2,834*	2,534	2,766	2,630	2,369*
Other operating income (expense)	493	435	362	390*	(621)	2,058	(723)	(920)*	439	(143)	593	(413)*
Operating income (loss)	(5,377)	(5,213)	(5,534)	(6,034)*	(5,198)	(4,957)	(5,400)	(6,621)*	(6,350)	(6,506)	(6,536)	(5,546)*
Interest income	—	—	—	year only	321	251	260	312*	193	118	104	73*
Interest expense	214	216	218	218*	217	211	212	233*	229	231	237	235*
Other income (expense)	493	435	362	390*	(621)	2,058	(723)	(920)*	439	(143)	593	(413)*
Income tax expense (benefit)	—	—	—	—	—	—	—	year only	(8)	(8)	(8)	(1)*
Net income (loss)	(4,961)	(4,905)	(5,293)	(5,729)*	(5,882)	(2,956)	(6,147)	(7,598)*	(5,850)	(6,543)	(5,548)	(5,880)*
Earnings per share, basic USD per share	(0.12)	(0.12)	(1.01)	—	(1.08)	(0.53)	(0.94)	(0.97)*	(0.65)	(0.71)	(0.55)	(0.55)*
Earnings per share, diluted USD per share	(0.12)	(0.12)	(1.01)	—	(1.08)	(0.53)	(0.94)	(0.97)*	(0.65)	(0.71)	(0.55)	(0.55)*
Weighted average shares, basic thousands of shares	41,332	41,527	5,221	—	5,459	5,553	6,564	7,793*	8,996	9,260	10,055	10,682*
Weighted average shares, diluted thousands of shares	41,332	41,527	5,221	—	5,459	5,553	6,564	7,793*	8,996	9,260	10,055	10,682*

Balance sheet

CSV

Fiscal quarters (PLUR's year ends in late June)

In thousands of dollars	Q1 FY24Sep 30, 2023	Q2 FY24Dec 31, 2023	Q3 FY24Mar 31, 2024	Q4 FY24Jun 30, 2024	Q1 FY25Sep 30, 2024	Q2 FY25Dec 31, 2024	Q3 FY25Mar 31, 2025	Q4 FY25Jun 30, 2025	Q1 FY26Sep 30, 2025	Q2 FY26Dec 31, 2025	Q3 FY26Mar 31, 2026	Q4 FY26Jun 30, 2026
Cash and cash equivalents	5,253	5,468	7,081	6,783	3,198	7,229	8,499	5,895	4,259	4,690	3,419	3,529
Prepaid and other current assets	1,354	1,259	1,087	868	1,008	656	597	824	1,143	929	816	810
Total current assets	35,258	32,252	27,367	31,107	27,032	22,370	27,455	22,095	16,921	13,804	10,463	8,730
Property and equipment, net	768	788	769	688	846	911	1,590	1,823	1,764	1,722	—	1,566
Right-of-use asset	7,472	7,340	7,151	6,558	6,398	6,236	7,034	6,900	6,753	6,551	5,525	6,164
Goodwill	—	—	—	—	—	—	—	3,136	3,136	3,136	3,136	3,136
Total assets	44,542	41,564	36,390	39,527	35,442	30,861	37,407	38,683	33,672	30,596	26,057	24,878
Accrued liabilities	1,024	1,012	958	1,223	1,103	841	1,579	1,178	884	566	700	928
Total current liabilities	4,322	4,530	4,526	4,454	4,583	4,440	5,705	32,328	32,160	32,346	32,006	32,719
Lease liability, non-current	5,430	5,403	5,343	5,026	4,938	4,903	5,640	6,102	6,029	6,144	5,600	6,487
Accumulated deficit	(404,545)	(409,450)	(414,743)	(420,472)	(426,354)	(429,310)	(435,457)	(443,055)	(448,905)	(455,448)	(460,996)	(466,876)
Total stockholders' equity	8,901	4,399	(356)	96	(5,283)	(8,028)	(4,474)	(6,842)	(11,360)	(14,608)	(18,603)	(23,036)
Total liabilities and equity	44,542	41,564	36,390	39,527	35,442	30,861	37,407	38,683	33,672	30,596	26,057	24,878
Common shares outstanding (cover page) thousands of shares	41,480	41,480	5,389	5,470	5,559	6,997	7,833	8,156	9,254	10,051	10,790	12,345

Cash flows

CSV

Fiscal quarters (PLUR's year ends in late June)

In thousands of dollars	Q1 FY24Sep 30, 2023	Q2 FY24Dec 31, 2023	Q3 FY24Mar 31, 2024	Q4 FY24Jun 30, 2024	Q1 FY25Sep 30, 2024	Q2 FY25Dec 31, 2024	Q3 FY25Mar 31, 2025	Q4 FY25Jun 30, 2025	Q1 FY26Sep 30, 2025	Q2 FY26Dec 31, 2025	Q3 FY26Mar 31, 2026	Q4 FY26Jun 30, 2026
Net income (loss)	(4,961)	(4,905)	(5,293)	(5,729)*	(5,882)	(2,956)	(6,147)	(7,598)*	(5,850)	(6,543)	(5,548)	(5,880)*
Stock-based compensation	836	573*	618*	591*	558	256*	491*	838*	1,350	763*	1,137*	476*
Depreciation and amortization	—	—	—	—	—	—	—	year only	—	—	—	year only
Net cash from operating activities	(5,857)	(3,649)*	(4,202)*	(4,313)*	(4,064)	(4,628)*	(4,303)*	(5,216)*	(5,428)	(5,205)*	(4,512)*	(4,443)*
Purchases of property and equipment	103	121*	89*	10*	208	112*	577*	721*	116	447*	44*	26*
Net cash from investing activities	5,802	3,919*	5,668*	(4,805)*	585	8,645*	(4,232)*	3,028*	3,850	2,658*	1,786*	1,609*
Proceeds from issuing common stock	—	—	—	year only	—	—	—	(388)*	—	—	1,249*	1,282*
Net cash from financing activities	—	—	—	year only	—	—	—	(435)*	—	—	1,378*	2,817*
Net change in cash	(97)	327*	1,505*	(320)*	(3,455)	4,074*	1,402*	(2,496)*	(1,600)	257*	(1,261)*	(16)*

Compare with peers

SIC 2836 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen

SIC 2836 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
Runway shows only for companies burning cash with under $10B of public float.
* marks a quarter worked out from the filing totals: for a 10-K, the year less the first three quarters; for a 10-Q, the year-to-date total less the earlier one.
A cell reading “not reported” means the filings give no figure for that quarter alone.

Company	Cash ($K)	Revenue, quarter ($K)	Operating cash flow, quarter ($K)	Shares outstanding	Runway	Quarter
Pluri	3,529	335*	(4,443)*	12.3M	0.8 quarters	Q4 FY26 10-KJun 30, 2026
ProPhase Labs	20	1,011	(78)*	15.6M	0.3 quarters	Q2 FY26 10-QJun 30, 2026
Akari Therapeutics	7,694	not reported	(3,109)*	155.8B	2.5 quarters	Q2 FY26 10-QJun 30, 2026
X4 Pharmaceuticals	195,095	2,400	(20,788)*	99.1M	9.4 quarters	Q2 FY26 10-QJun 30, 2026
CalciMedica	18,617	not reported	(4,620)*	34.1M	4.0 quarters	Q2 FY26 10-QJun 30, 2026
Lipocine	4,979	190	(3,028)*	8.2M	7.7 quarters	Q2 FY26 10-QJun 30, 2026
Edesa Biotech	10,300	not reported	(3,083)*	9.6M	3.3 quarters	Q3 FY26 10-QJun 30, 2026
GeoVax Labs	3,143	not reported	(3,658)*	7.4M	0.9 quarters	Q2 FY26 10-QJun 30, 2026
Earth Science Tech	631	9,026	707	287.6M	—	Q1 FY27 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.